TuHURA Biosciences, Inc./NV

HURA · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.1B · 22 employees
342
SEC Filings
$2.05
Close 2026-09-23
22
Employees

Business Summary

TuHURA Biosciences is a phase 3 clinical stage immuno-oncology company developing novel therapeutics to overcome resistance to cancer immunotherapies. Its lead product IFx-2.0 is an innate immune agonist in a Phase 3 trial combined with Keytruda for Merkel cell carcinoma. The company also holds TBS-2025, a VISTA-inhibiting monoclonal antibody acquired via Kineta for AML treatment, and a Delta Opioid Receptor ADC technology targeting myeloid-derived suppressor cells.

Latest Stock Quote

HURA 2026-09-23 $2.05 O:$2.1 H:$2.1 L:$2.04 Vol:0.2M VWAP:$2.0637
origin leaf: null

Next Earnings

expected 2026-12-17

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-312025-12-310001193125-26-134950EDGAR90K words
2025-03-312024-12-310000950170-25-047921EDGAR101K words
2024-10-072024-06-300000950170-24-113321EDGAR67K words
2023-09-182023-06-300000950170-23-048588EDGAR72K words
2022-09-272022-06-300000950170-22-018865EDGAR—
2021-09-282021-06-300001564590-21-049235EDGAR—
2020-09-182020-06-300001564590-20-044019EDGAR—
2019-09-092019-06-300001213900-19-017497EDGAR—
2018-09-242018-06-300001213900-18-012876EDGAR—
2017-09-272017-06-300001213900-17-010055EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-142026-06-300001193125-26-350451EDGAR19K words
2025-11-142025-09-300001193125-25-281539EDGAR26K words
2025-08-142025-06-300000950170-25-108972EDGAR23K words
2025-05-152025-03-310000950170-25-072745EDGAR22K words
2024-11-142024-09-300000950170-24-127199EDGAR18K words
2024-05-142024-03-310000950170-24-059694EDGAR22K words
2024-02-142023-12-310000950170-24-015204EDGAR20K words
2023-11-132023-09-300000950170-23-062915EDGAR18K words
2023-05-112023-03-310000950170-23-020854EDGAR22K words
2023-02-142022-12-310000950170-23-002805EDGAR22K words
2022-11-092022-09-300000950170-22-023988EDGAR—
2022-05-132022-03-310000950170-22-009809EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-09-240001193125-26-401140EDGAR1K words
2026-09-170001193125-26-394473EDGAR1K words
2026-09-160001193125-26-393206EDGAR11K words
2026-09-040001193125-26-383797EDGAR1K words
2026-08-210001193125-26-361272EDGAR1K words
2026-08-190001193125-26-357087EDGAR2K words
2026-08-140001193125-26-350425EDGAR1K words
2026-08-130001193125-26-349540EDGAR1K words
2026-07-290001193125-26-324174EDGAR1K words
2026-04-010001193125-26-135766EDGAR1K words

342 total filings indexed. 310 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

immuno-oncology merkel-cell-carcinoma acute-myeloid-leukemia-(aml) cancer-immunotherapy-resistance fda-accelerated-approval-pathway fda-project-front-runner special-protocol-assessment-(spa)

Company Identity

CIK0001498382
TickerHURA
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedNV
Websitehttps://www.tuhurabio.com
Listed2024-10-18

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: 7ac07eead5e1cc711ba22061b114ad1f454c21af62863bada81566887c512d39
parent: 628d4dcce582d4779589aa27cd015a6644a95c18408d3fc3fff41a78b84d25a5
content hash: 6b0688f9e2b88a245de23459f67b3256a7227d56ac9484c955ab0f5108f72b44
signed: 2026-09-29T19:01:39.249Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up HURA using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on HURA, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/HURA (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.